e-Drug3D 503 |
TRIFLURIDINE
|
cas 70-00-8 |
CLASS SENSORY |
ROUTE (list) OPHTHALMIC ORAL |
PK parameters |
Target TARGET DNA |
DrugCentral Unknown |
Download SDF file | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione Formula: Calculated chemical properties: MW 296.21 NB_atoms 20 XLogP -0.80 PSA 99.102 NB_HD 3 NB_HA 7 fsp3 0.60 Lipinski(0=no;1=yes) 1 |
FDA NDA 018299 (pdf not found) INN (TRIFLURIDINE) VIROPTIC (MONARCH PHARMS) APPROVAL= AP YEAR= 1980 NEWMOLECULARENTITY NDA 074311 (pdf not found) INN (TRIFLURIDINE) TRIFLURIDINE (SANDOZ) APPROVAL= AP YEAR= 1995 NDA 207981 (label) INN (TIPIRACIL HYDROCHLORIDE ; TRIFLURIDINE) LONSURF (TAIHO ONCOLOGY) APPROVAL= AP YEAR= 2015 NDA 205438 (pdf not found) INN (TRIFLURIDINE) TRIFLURIDINE (HIKMA) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 214036 (pdf not found) INN (TRIFLURIDINE ; TIPIRACIL) TRIFLURIDINE; TIPIRACIL (INTAS PHARMS LTD) APPROVAL= TA YEAR= 2022 NDA 214008 (pdf not found) INN (TIPIRACIL HYDROCHLORIDE ; TRIFLURIDINE) TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE (NATCO) APPROVAL= AP YEAR= 2023 NDA 214024 (pdf not found) INN (TIPIRACIL HYDROCHLORIDE ; TRIFLURIDINE) TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE (MSN) APPROVAL= AP YEAR= 2025 |
Other links: |